A. A. . Zakir and M. U. Mohd Siddique, “#165 Design and synthesis of allosteric fourth-generation EGFR tyrosine kinase triple mutant selective inhibitors for the treatment of non-small cell lung cancer”, J Pharm Chem, vol. 8, no. Supplement, Jul. 2022, Accessed: Nov. 22, 2024. [Online]. Available: https://pubs.vensel.org/index.php/jphchem/article/view/258